[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:alzheimer-s-disease":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":312,"states":341},"Alzheimer's Disease",331,243,[8,16,23,30,36,42,48,54,60,67,73,79,85,91,97,103,110,116,122,129,135,141,147,153,159,165,171,177,183,189,195,201,207,213,219,225,231,237,242,247,252,258,264,270,276,282,288,294,300,306],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05552157","A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation",[12],"Phase 2\u002FPhase 3","RECRUITING","2026-08-26T02:15:42.447052Z","2026-07-30T01:46:14.463117Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07011745","A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease",[20],"Phase 3","2026-08-26T02:15:36.077529Z","2026-07-30T01:46:14.435459Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":28,"content_modified":29},"NCT04601038","Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)",[27],"Phase 2","2026-08-26T02:19:25.538428Z","2026-07-19T19:36:05.114980Z",{"nct_id":31,"title":32,"phases":33,"status":13,"updated_at":34,"content_modified":35},"NCT05822362","CBD for Individuals at Risk for Alzheimer's Disease",[27],"2026-08-26T02:18:05.435729Z","2026-07-05T05:32:16.814711Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT07011732","A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)",[20],"2026-08-26T02:15:13.282904Z","2026-07-05T05:32:16.732821Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT06937229","A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)",[20],"2026-08-26T02:19:22.562392Z","2026-07-05T05:32:16.703429Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT06808984","Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease",[27],"2026-08-26T02:17:04.346841Z","2026-07-05T05:32:16.693932Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT07553338","Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease",[27],"2026-08-26T02:19:24.527214Z","2026-07-05T05:32:16.685869Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":65,"content_modified":66},"NCT07651319","Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease",[64],"Phase 1\u002FPhase 2","2026-08-26T02:17:35.666428Z","2026-06-17T02:29:30.061241Z",{"nct_id":68,"title":69,"phases":70,"status":13,"updated_at":71,"content_modified":72},"NCT07602582","A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).",[20],"2026-08-26T02:16:15.345907Z","2026-05-29T15:36:40.221088Z",{"nct_id":74,"title":75,"phases":76,"status":13,"updated_at":77,"content_modified":78},"NCT04436081","Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease",[27],"2026-08-26T02:18:16.220328Z","2026-05-13T02:55:06.251166Z",{"nct_id":80,"title":81,"phases":82,"status":13,"updated_at":83,"content_modified":84},"NCT07284472","Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia",[12],"2026-08-26T02:18:15.214990Z","2026-05-05T02:43:29.509130Z",{"nct_id":86,"title":87,"phases":88,"status":13,"updated_at":89,"content_modified":90},"NCT06835283","Novel Brain Stimulation Treatment for Neuropsychiatric Symptoms in Alzheimer's Disease",[],"2026-08-26T02:19:28.327680Z","2026-05-05T02:43:29.359431Z",{"nct_id":92,"title":93,"phases":94,"status":13,"updated_at":95,"content_modified":96},"NCT05295615","Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease",[],"2026-08-26T02:19:18.331180Z","2026-05-05T02:43:29.155742Z",{"nct_id":98,"title":99,"phases":100,"status":13,"updated_at":101,"content_modified":102},"NCT04896775","NiteCAPP: Web-based Interventions for Insomnia in Rural Dementia Caregivers",[],"2026-08-26T02:17:54.420226Z","2026-05-05T02:43:29.139083Z",{"nct_id":104,"title":105,"phases":106,"status":13,"updated_at":108,"content_modified":109},"NCT06945614","Exploratory Clinical Study to Assess Safety and Efficacy of Xenon Gas Inhalation to Control Neuroinflammation",[107],"Phase 1","2026-08-26T02:19:16.454910Z","2026-05-05T02:43:29.138732Z",{"nct_id":111,"title":112,"phases":113,"status":13,"updated_at":114,"content_modified":115},"NCT06781333","Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.",[27],"2026-08-26T02:17:05.997056Z","2026-05-05T02:43:28.971682Z",{"nct_id":117,"title":118,"phases":119,"status":13,"updated_at":120,"content_modified":121},"NCT06484244","Locomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease",[],"2026-08-26T02:15:14.574786Z","2026-05-05T02:43:28.886726Z",{"nct_id":123,"title":124,"phases":125,"status":13,"updated_at":127,"content_modified":128},"NCT05004987","Aβ Dynamics in LLMD",[126],"Phase 4","2026-08-26T02:17:21.315591Z","2026-05-05T02:43:28.866314Z",{"nct_id":130,"title":131,"phases":132,"status":13,"updated_at":133,"content_modified":134},"NCT06651567","A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia",[27],"2026-08-26T02:15:01.639696Z","2026-05-05T02:43:28.704728Z",{"nct_id":136,"title":137,"phases":138,"status":13,"updated_at":139,"content_modified":140},"NCT07033494","A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)",[27],"2026-08-26T02:18:33.598205Z","2026-05-05T02:43:28.652372Z",{"nct_id":142,"title":143,"phases":144,"status":13,"updated_at":145,"content_modified":146},"NCT06372821","A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK",[107],"2026-08-26T02:17:33.807405Z","2026-05-05T02:43:28.517514Z",{"nct_id":148,"title":149,"phases":150,"status":13,"updated_at":151,"content_modified":152},"NCT06585787","A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)",[20],"2026-08-26T02:18:48.678868Z","2026-05-05T02:43:28.516385Z",{"nct_id":154,"title":155,"phases":156,"status":13,"updated_at":157,"content_modified":158},"NCT05397639","Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type",[20],"2026-08-26T02:16:21.385056Z","2026-05-05T02:43:28.510738Z",{"nct_id":160,"title":161,"phases":162,"status":13,"updated_at":163,"content_modified":164},"NCT05511363","A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)",[20],"2026-08-26T02:15:17.167444Z","2026-05-05T02:43:28.366461Z",{"nct_id":166,"title":167,"phases":168,"status":13,"updated_at":169,"content_modified":170},"NCT05655195","Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy",[],"2026-08-26T02:18:51.009190Z","2026-05-05T02:43:28.312466Z",{"nct_id":172,"title":173,"phases":174,"status":13,"updated_at":175,"content_modified":176},"NCT07178210","Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease",[],"2026-08-26T02:15:20.225313Z","2026-05-05T02:43:28.190977Z",{"nct_id":178,"title":179,"phases":180,"status":13,"updated_at":181,"content_modified":182},"NCT05667649","Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease",[107],"2026-08-26T02:15:33.331531Z","2026-05-05T02:43:28.119265Z",{"nct_id":184,"title":185,"phases":186,"status":13,"updated_at":187,"content_modified":188},"NCT06052163","Bumetanide in Patients With Alzheimer's Disease",[27],"2026-08-26T02:18:31.944757Z","2026-05-05T02:43:28.102928Z",{"nct_id":190,"title":191,"phases":192,"status":13,"updated_at":193,"content_modified":194},"NCT05151562","Music Therapy for Patients With Alzheimer's Disease",[],"2026-08-26T02:18:58.141497Z","2026-05-05T02:43:27.987994Z",{"nct_id":196,"title":197,"phases":198,"status":13,"updated_at":199,"content_modified":200},"NCT06126224","A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)",[20],"2026-08-26T02:16:55.892527Z","2026-05-05T02:43:27.977706Z",{"nct_id":202,"title":203,"phases":204,"status":13,"updated_at":205,"content_modified":206},"NCT06775964","Stem Cell Therapy for Early Alzheimer's Disease",[64],"2026-08-26T02:17:01.714035Z","2026-05-05T02:43:27.929167Z",{"nct_id":208,"title":209,"phases":210,"status":13,"updated_at":211,"content_modified":212},"NCT06489548","Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease",[27],"2026-08-26T02:18:37.277498Z","2026-05-05T02:43:27.830250Z",{"nct_id":214,"title":215,"phases":216,"status":13,"updated_at":217,"content_modified":218},"NCT07496918","Brain Effects of Gamma Frequency Sensory Stimulation (40Hz Light, Sound and Other Devices)",[27],"2026-08-26T02:17:15.156099Z","2026-05-05T02:43:27.803329Z",{"nct_id":220,"title":221,"phases":222,"status":13,"updated_at":223,"content_modified":224},"NCT04500847","Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD",[107],"2026-08-26T02:19:27.519777Z","2026-05-05T02:43:27.760472Z",{"nct_id":226,"title":227,"phases":228,"status":13,"updated_at":229,"content_modified":230},"NCT05543681","Clinical Trial on Agitation in Alzheimer's Dementia",[27],"2026-08-26T02:19:26.493949Z","2026-05-05T02:43:27.675605Z",{"nct_id":232,"title":233,"phases":234,"status":13,"updated_at":235,"content_modified":236},"NCT06639282","Repurposing Siponimod for Alzheimer's Disease",[27],"2026-08-26T02:16:58.658552Z","2026-05-05T02:43:27.636898Z",{"nct_id":238,"title":239,"phases":240,"status":13,"updated_at":108,"content_modified":241},"NCT06792877","Mindfulness for Cognition in Early-stage Alzheimer's Disease",[],"2026-05-05T02:43:27.627819Z",{"nct_id":243,"title":244,"phases":245,"status":13,"updated_at":108,"content_modified":246},"NCT06976216","A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease",[20],"2026-05-05T02:43:27.506933Z",{"nct_id":248,"title":249,"phases":250,"status":13,"updated_at":175,"content_modified":251},"NCT03082755","Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease",[126],"2026-05-05T02:43:27.504740Z",{"nct_id":253,"title":254,"phases":255,"status":13,"updated_at":256,"content_modified":257},"NCT06947941","A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)",[20],"2026-08-26T02:15:37.042762Z","2026-05-05T02:43:27.421509Z",{"nct_id":259,"title":260,"phases":261,"status":13,"updated_at":262,"content_modified":263},"NCT06052254","Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type",[27],"2026-08-26T02:15:40.343619Z","2026-05-05T02:43:27.419964Z",{"nct_id":265,"title":266,"phases":267,"status":13,"updated_at":268,"content_modified":269},"NCT05904132","Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease",[],"2026-08-26T02:16:45.157238Z","2026-05-05T02:43:27.393758Z",{"nct_id":271,"title":272,"phases":273,"status":13,"updated_at":274,"content_modified":275},"NCT07224607","Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study",[],"2026-08-26T02:15:18.897219Z","2026-05-05T02:43:27.392972Z",{"nct_id":277,"title":278,"phases":279,"status":13,"updated_at":280,"content_modified":281},"NCT05591027","Safety and Target Engagement of Centella Asiatica in Cognitive Impairment",[107],"2026-08-26T02:18:55.570428Z","2026-05-05T02:43:27.335628Z",{"nct_id":283,"title":284,"phases":285,"status":13,"updated_at":286,"content_modified":287},"NCT06298474","The BRAIN App (Phase 2 SBIR)",[],"2026-08-26T02:17:00.709807Z","2026-05-05T02:43:27.312458Z",{"nct_id":289,"title":290,"phases":291,"status":13,"updated_at":292,"content_modified":293},"NCT06189963","Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease",[64],"2026-08-26T02:16:51.982021Z","2026-05-05T02:43:27.132573Z",{"nct_id":295,"title":296,"phases":297,"status":13,"updated_at":298,"content_modified":299},"NCT05016219","Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients",[],"2026-08-26T02:17:30.961790Z","2026-05-05T02:43:27.110249Z",{"nct_id":301,"title":302,"phases":303,"status":13,"updated_at":304,"content_modified":305},"NCT06718686","Rifaximin SSD in Dementia Trial",[64],"2026-08-26T02:19:12.219640Z","2026-05-05T02:43:27.095484Z",{"nct_id":307,"title":308,"phases":309,"status":13,"updated_at":310,"content_modified":311},"NCT05997030","Low-Intensity Focused Ultrasound (LIFU) Neuromodulation",[],"2026-08-26T02:15:22.311223Z","2026-05-05T02:43:26.955200Z",[313,317,321,325,328,331,335,338],{"biomarker":314,"count":315,"slug":316},"Amyloid",28,"amyloid",{"biomarker":318,"count":319,"slug":320},"Microtubule-Associated Protein Tau",10,"microtubule-associated-protein-tau",{"biomarker":322,"count":323,"slug":324},"Amyloid beta peptide",9,"amyloid-beta-peptide",{"biomarker":326,"count":323,"slug":327},"APOE Gene","apoe-gene",{"biomarker":329,"count":330,"slug":329},"p-tau217",5,{"biomarker":332,"count":333,"slug":334},"AD biomarkers",3,"ad-biomarkers",{"biomarker":336,"count":333,"slug":337},"Presenilin-1","presenilin-1",{"biomarker":339,"count":333,"slug":340},"Presenilin-2","presenilin-2",[342,346,350,354,358,362,366,370,373,377,381,385,388,392,396,400,404,408,411,415,418,422,425,428],{"state":343,"count":344,"slug":345},"California",75,"california",{"state":347,"count":348,"slug":349},"Florida",69,"florida",{"state":351,"count":352,"slug":353},"Massachusetts",61,"massachusetts",{"state":355,"count":356,"slug":357},"Texas",58,"texas",{"state":359,"count":360,"slug":361},"New York",57,"new-york",{"state":363,"count":364,"slug":365},"Arizona",40,"arizona",{"state":367,"count":368,"slug":369},"Missouri",35,"missouri",{"state":371,"count":368,"slug":372},"North Carolina","north-carolina",{"state":374,"count":375,"slug":376},"Pennsylvania",33,"pennsylvania",{"state":378,"count":379,"slug":380},"Illinois",32,"illinois",{"state":382,"count":383,"slug":384},"New Jersey",30,"new-jersey",{"state":386,"count":383,"slug":387},"Ohio","ohio",{"state":389,"count":390,"slug":391},"Georgia",29,"georgia",{"state":393,"count":394,"slug":395},"Maryland",22,"maryland",{"state":397,"count":398,"slug":399},"Tennessee",21,"tennessee",{"state":401,"count":402,"slug":403},"Washington",20,"washington",{"state":405,"count":406,"slug":407},"Indiana",19,"indiana",{"state":409,"count":406,"slug":410},"Michigan","michigan",{"state":412,"count":413,"slug":414},"Colorado",18,"colorado",{"state":416,"count":413,"slug":417},"Minnesota","minnesota",{"state":419,"count":420,"slug":421},"Connecticut",15,"connecticut",{"state":423,"count":420,"slug":424},"Rhode Island","rhode-island",{"state":426,"count":420,"slug":427},"Virginia","virginia",{"state":429,"count":430,"slug":431},"Nevada",14,"nevada"]